Aberrant expression of splicing factors in newly diagnosed acute myeloid leukemia

Onkologie

Volumn 35, Issue 6, 2012, Pages 335-340

  Liu, Jing ^a   Huang, Bo ^a   Xiao, Yun ^a   Xiong, Huo Mei ^a   Li, Jing ^a   Feng, Dan Qin ^a   Chen, Xi Min ^a   Zhang, Hai Bin ^a   Wang, Xiao Zhong ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; Alternative splicing; Quantitative real time polymerase chain reaction; Serine arginine rich

Indexed keywords

CASPASE 8; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; MESSENGER RNA; MESSENGER RNA PRECURSOR; PROTEIN SRSF1; PROTEIN SRSF2; PROTEIN SRSF3; PROTEIN SRSF4; PROTEIN SRSF5; PROTEIN SRSF6; PROTEIN SRSF7; SERINE ARGININE RICH PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER PATIENT; CASP8 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EARLY DIAGNOSIS; FEMALE; GAPDH GENE; GENE; GENE EXPRESSION; HNRNPA1 GENE; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; MALE; ONCOGENE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SRSF1 GENE; SRSF2 GENE; SRSF3 GENE; SRSF4 GENE; SRSF5 GENE; SRSF6 GENE; SRSF7 GENE; UPREGULATION;

ADULT; AGED; ALTERNATIVE SPLICING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MUTATION; ONCOGENES; RNA SPLICING; YOUNG ADULT;

EID: 84862877752     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000338941     Document Type: Article

References (30)

1. Wang ET, Sandberg R, et al.: Alternative isoform regulation in human tissue transcriptomes. Nature 2008;456:470-476. (Pubitemid 352759009)
2. Venables JP: Aberrant and alternative splicing in cancer. Cancer Res 2004;64:7647-7654. (Pubitemid 39446889)
3. Liu X, Zhang Q, et al.: Overexpression of an isoform of AML1 in acute leukemia and its potential role in leukemogenesis. Leukemia 2009;23:739-745.
4. Tsuzuki S, Hong D, et al.: Isoform-specific potentiation of stem and progenitor cell engraftment by AML1/RUNX1. PLoS Med 2007;4:172.
5. Hamid R, Patterson J, Brandt SJ: Genomic structure, alternative splicing and expression of TG-interacting factor, in human myeloid leukemia blasts and cell lines. Biochim Biophys Acta 2008;1779: 347-355. (Pubitemid 351662711)
6. Eberle I, Pless B, et al.: Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells. Nucleic Acids Res 2010;38:5384-5395.
7. Shiote Y, Ouchida M, et al.: Multiple splicing variants of Naf1/ABIN-1 transcripts and their alterations in hematopoietic tumors. Int J Mol Med 2006; 18:917-923.
8. Suh WS, Kim YS, et al.: Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL. Leukemia 2003;17:2122-2129. (Pubitemid 37428377)
9. Kim HJ, Park BH, et al.: Fas, Fas-associated death domain-like interleukin 1beta-converting enzymelike inhibitory protein, and apoptotic features of elderly acute myeloid leukemia based on response to induction chemotherapy. Int J Hematol 2005;82: 327-332.
10. Adamia S, Avet-Loiseau H, et al.: Identification of potential therapeutic targets using genome-wide analysis of alternative splicing (AS) in patients with acute myeloid leukemia (AML). Blood (ASH Ann Meet Abstr) 2010;116:abstr 177.
11. Graveley BR: Sorting out the complexity of SR protein functions. RNA 2000;6:1197-1211.
12. Black DL: Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2003;72:291-336. (Pubitemid 36930448)
13. Lareau LF, Inada M, et al.: Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 2007;446: 926-929. (Pubitemid 46633161)
14. Zheng ZM: Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression. J Biomed Sci 2004; 11:278-294.
15. Piekielko-Witkowska A, Wiszomirska H, et al.: Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors. PLoS One 2010;5:13690.
16. Chandradas S, Deikus G, et al.: Antagonistic roles of four SR proteins in the biosynthesis of alternatively spliced tissue factor transcripts in monocytic cells. J Leukoc Biol 2010;87:147-152.
17. Watanuki T, Funato H, et al.: Increased expression of splicing factor SRp20 mRNA in bipolar disorder patients. J Affect Disord 2008;110:62-69.
18. Horiuchi T, Himeji D, et al.: Dominant expression of a novel splice variant of caspase-8 in human peripheral blood lymphocytes. Biochem Biophys Res Commun 2000;272:877-881. (Pubitemid 30420729)
19. Mohr A, Zwacka RM, et al.: Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis. Oncogene 2005;24:2421-2429. (Pubitemid 40546700)
20. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408. (Pubitemid 34164012)
21. Miller MA, Karacay B, et al.: Caspase 8L, a novel inhibitory isoform of caspase 8, is associated with undifferentiated neuroblastoma. Apoptosis 2006; 11:15-24. (Pubitemid 43151640)
22. Merdzhanova G, Edmond V, et al.: E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35. Cell Death Differ 2008;15: 1815-1823.
23. Long JC, Caceres JF: The SR protein family of splicing factors: master regulators of gene expression. Biochem J 2009;417:15-27.
24. Fischer DC, Noack K, et al.: Expression of splicing factors in human ovarian cancer. Oncol Rep 2004; 11:1085-1090.
25. Stickeler E, Kittrell F, et al.: Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 1999;18:3574-3582. (Pubitemid 29322382)
26. Ghigna C, Moroni M, et al.: Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res 1998;58:5818-5824. (Pubitemid 29006424)
27. Goncalves V, Matos P, Jordan P: Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways. Hum Mol Genet 2009;18:3696-3707.
28. Solis AS, Peng R, et al.: Growth hormone deficiency and splicing fidelity: two serine/arginine-rich proteins, ASF/SF2 and SC35, act antagonistically. J Biol Chem 2008;283:23619-23626.
29. Caceres JF, Stamm S, et al.: Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 1994;265:1706-1709. (Pubitemid 24314901)
30. Jumaa H, Nielsen PJ: The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. EMBO J 1997;16:5077-5085. (Pubitemid 27348416)